AbbVie Inc.ABBVNYSE
Loading
SG&A Expenses Over TimeStrong
Percentile Rank86
3Y CAGR-2.8%
5Y CAGR+4.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-2.8%/yr
vs +19.8%/yr prior
5Y CAGR
+4.4%/yr
Recent deceleration
Acceleration
-22.6pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $14.01B | -5.0% |
| 2024 | $14.75B | +14.6% |
| 2023 | $12.87B | -15.6% |
| 2022 | $15.26B | +23.6% |
| 2021 | $12.35B | +9.3% |
| 2020 | $11.30B | +62.8% |
| 2019 | $6.94B | -6.2% |
| 2018 | $7.40B | +17.5% |
| 2017 | $6.29B | +7.0% |
| 2016 | $5.88B | - |